EnglishArabicChinese (Simplified)CzechDanishDutchFrenchGermanHindiItalianJapanesePolishPortugueseRussianSpanishHebrewUkrainianHungarianWelshArmenianUrduBengaliPunjabiSomaliKurdish (Kurmanji)

Paediatric Continence Forum logo and transition awards The first ever Paediatric Continence Forum Awards have been launched today to recognise excellence in transition of care from children to adult continence services (bladder and bowel care) in the UK.

The Awards, the first of their kind, are a collaborative exercise between the Paediatric Continence Forum (PCF) and the company Essity.

Promoting best practice

It is well documented that too many young people moving into adult NHS services experience a poor standard of transition, without proper care pathways to ensure that the quality of their care is upheld. These Awards aim to redress this situation through recognising best practice in this area of child health – such as good integrated working across child and adult services and providing appropriate support for the young person in a way that enhances their independence.

Who can apply? 

Applications are open to those working with children, adults, or from a combination of adult and paediatric services. Applicants will be expected to demonstrate excellence in the application of the NICE Quality Standards QS 140 “Transition from children from children’s to adults’ services” and NICE guidance NG43 “Transition from children’s to adults’ services for young people using health or social care services”.

Judging panel 

Entries will be judged by a multidisciplinary team of clinicians with extensive experience in paediatric continence care and transition. The winners will be announced in January 2020 and will be given an award certificate, as well as a digital badge which can be used to promote their win in electronic communications and on social media.

Dr Penny Dobson MBE Chair of the Paediatric Continence Forum, said:

“About 900,000 children and young people in the UK experience continence problems. These can be bedwetting, daytime wetting or constipation/soiling, or a combination of all three. They occur at a formative time for children and can affect their health, wellbeing and emotional development. Most are treatable, but community-based NHS treatment services vary hugely across the country. This situation causes a common “disconnect” as young people transition from child to adult NHS services. We are excited to be part of this new award scheme which will encourage and support good practice in this often neglected area of child health.”

More information and how to apply 

Notes to editors

Judging panel:

1. Susan Affleck, Head of Nursing, Children's Services, and Clinical Nurse Specialist in Paediatric Urology, St George's Hospital
2. Juliette Rayner, Chief Executive, ERIC, The Children's Bowel and Bladder Charity
3. Davina Richardson, Children's Specialist Nurse, Bladder & Bowel UK
4. Nicholas Madden, past President British Association of Paediatric Urologists

Important dates:
Entries open: now
Deadline for submissions: 22nd November
Results announced: January 2020

About the Paediatric Continence Forum

The Paediatric Continence Forum (PCF) is an independent national campaign group which was set up in 2003 to improve government awareness of the needs of children and young people with continence problems and to improve NHS services in this area of child health. Its membership comprises key paediatricians and specialist nurses, with formal representation from the charities ERIC The Children’s Bowel and Bladder Charity and Bladder & Bowel UK, as well as the Royal College of Paediatrics and Child Health (RCPCH), the Royal College of Nursing (RCN), the School and Public Health Nurses Association (SAPHNA) and the Community Practitioners and Health Visitors Association ( CPHVA)

The PCF has six commercial members who support its work. These are: Coloplast UK Ltd, Ferring Pharmaceuticals Ltd, Kimberly-Clark Europe Ltd, Norgine Pharmaceuticals Ltd, Essity (formerly SCA Hygiene Products Ltd) and Closomat Ltd.

About Essity

Essity is a leading global hygiene and health company dedicated to improving well-being through products and services, essentials for everyday life. The name Essity stems from the words essentials and necessities. Our sustainable business model creates value for people and nature. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands, such as JOBST, Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 47,000 employees and net sales in 2018 amounted to approximately SEK 118.5bn (EUR 11.6bn). The headquarters is located in Stockholm, Sweden, and the company is listed on Nasdaq Stockholm.